
CAR T cell therapy shows promising results in treating high-risk childhood neuroblastoma.


coremsg

Children with relapsed or treatment-refractory neuroblastoma could soon be treated with third-generation of CAR T cells with a 'suicide' safety switch, after a promising results from phase 1/2 trial.

CAR T Cells Offer Hope in High-Risk Childhood Neuroblastoma

car-t-cells-show-promise-in-treating-high-risk-childhood-neuroblastoma


CAR T Cells Show Promise in Treating High-Risk Childhood Neuroblastoma
